Form 8-K Iterum Therapeutics plc For: Aug 14
Last iterum therapeutics plc earnings: 11/12 04:30 pm
Check Earnings Report
| Impact snapshot | Event time: | ITRM | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
ITRM alerts
ITRM alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ITRM alerts
High impacting Iterum Therapeutics Plc news events
Weekly update
A roundup of the hottest topics
ITRM
News
- Iterum Therapeutics files US application for sulopenem in urinary tract infections [Seeking Alpha]Seeking Alpha
- Iterum Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Oral SulopenemGlobeNewswire
- Sarissa Capita discloses active stake in Iterum Therapeutics [Seeking Alpha]Seeking Alpha
- Iterum Therapeutics Reports Third Quarter 2020 Financial ResultsGlobeNewswire
- Iterum Therapeutics Announces Pricing of $17.5 Million Upsized Public OfferingGlobeNewswire
- More
ITRM
SEC Filings
- 11/23/20 - Form SC
- 11/23/20 - Form 3
- 11/16/20 - Form 10-Q
- ITRM's page on the SEC website
- More